How Drug Re-innovation Can Potentially Boost Pharma’s Depleting R&D Pipeline

The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...

Transforming Hub Services and Increasing Speed to Therapy

In this final installment of a three-part series on integrating comprehensive hub services and ...

Trends that Emerged from J.P. Morgan Week 2018

Every January, tens of thousands of healthcare CEOs, investors, and business development executives descend ...

Best Practices for Forging Strategic Sponsor-CRO Relationships

A true strategic partnership has benefits for both the sponsor and the contract research ...

Reimagining Clinical Trial Registries

Since its launch in 2000, ClinicalTrials.gov has steadily grown in size and currently hosts ...

My Transition from Traditional Consulting to an Analytics Role at an Ad Agency

To the average person, both “consulting” and “analytics” tend to be perceived as floating ...

Asking the Right Questions to Influence Behaviors

“No question is a bad question,” or so we’ve been taught. As a father ...

The HCP is Not Your Target—It’s Time to Re-Think HCP Message Targeting and Relevance

In the world of pharmaceutical communication and marketing strategy, the majority of effort is ...

4 Reasons Healthcare and Consumer Goods Marketing is Not So Different

In the world of marketing, I’ve heard people say that healthcare marketers are often ...

Step Up Your Trade Show Game with These Three Keys

How do you create a compelling, engaging—and even fun—trade show exhibit about a sensitive ...